BR0316843A - Derivados tetracìclicos contendo heteroátomo como moduladores seletivos do receptor de estrogênio - Google Patents

Derivados tetracìclicos contendo heteroátomo como moduladores seletivos do receptor de estrogênio

Info

Publication number
BR0316843A
BR0316843A BR0316843-3A BR0316843A BR0316843A BR 0316843 A BR0316843 A BR 0316843A BR 0316843 A BR0316843 A BR 0316843A BR 0316843 A BR0316843 A BR 0316843A
Authority
BR
Brazil
Prior art keywords
receptor modulators
estrogen receptor
selective estrogen
derivatives containing
tetracyclic derivatives
Prior art date
Application number
BR0316843-3A
Other languages
English (en)
Inventor
Ramesh M Kanojia
Nareshkumar F Jain
Raymond Ng
Zhihua Sui
Jiayi Xu
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of BR0316843A publication Critical patent/BR0316843A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

"DERIVADOS TETRACìCLICOS CONTENDO HETEROáTOMO COMO MODULADORES SELETIVOS DO RECEPTOR DE ESTROGêNIO". A presente invenção refere-se a novos derivados tetracíclicos contendo heteroátomo, composições farmacêuticas contendo-os, seu uso no tratamento e/ou prevenção de distúrbios mediados por um ou mais receptores de estrogênio e processos para a sua preparação. Os compostos da invenção são úteis no tratamento e/ou prevenção de distúrbios associados com a depleção de estrogênio tais como fogachos, secura vaginal, osteopenia e osteoporose; cânceres sensíveis a hormónio e hiperplasia da mama, endométrio, cerviz e próstata; endometriose, fibróides uterinos, osteoartrite e como agentes contraceptivos, isoladamente ou em combinação com um progestogênio ou antagonista de progestogênio.
BR0316843-3A 2002-12-02 2003-11-21 Derivados tetracìclicos contendo heteroátomo como moduladores seletivos do receptor de estrogênio BR0316843A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/307,735 US7329654B2 (en) 2001-12-19 2002-12-02 Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators
PCT/US2003/037419 WO2004050660A1 (en) 2002-12-02 2003-11-21 Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators

Publications (1)

Publication Number Publication Date
BR0316843A true BR0316843A (pt) 2005-11-01

Family

ID=32467796

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0316843-3A BR0316843A (pt) 2002-12-02 2003-11-21 Derivados tetracìclicos contendo heteroátomo como moduladores seletivos do receptor de estrogênio

Country Status (13)

Country Link
US (1) US7329654B2 (pt)
EP (1) EP1569939A1 (pt)
JP (1) JP2006514941A (pt)
CN (2) CN1745085A (pt)
AU (1) AU2003295822A1 (pt)
BR (1) BR0316843A (pt)
CA (1) CA2505857A1 (pt)
MX (1) MXPA05005897A (pt)
NZ (1) NZ539914A (pt)
PL (1) PL376803A1 (pt)
RU (1) RU2331645C2 (pt)
WO (1) WO2004050660A1 (pt)
ZA (1) ZA200505324B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1812417T1 (sl) * 2004-11-18 2009-04-30 Janssen Pharmaceutica Nv Novi derivati 2H-kromena kot selektivni modulatorji estrogenskega receptorja
EP1846386A2 (en) * 2005-01-21 2007-10-24 Janssen Pharmaceutica N.V. Novel coumarin derivatives as ion channel openers
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
LT2782584T (lt) 2011-11-23 2021-09-10 Therapeuticsmd, Inc. Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
WO2015089810A1 (en) 2013-12-20 2015-06-25 Merck Sharp & Dohme Corp. Fused tetracyclic heterocyclic compounds and methods of use thereof for the treatment of viral diseases
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
SG11202100145YA (en) * 2018-07-12 2021-02-25 Lilly Co Eli Selective estrogen receptor degraders
TWI702219B (zh) * 2018-07-12 2020-08-21 美商美國禮來大藥廠 選擇性雌激素受體降解劑
CN111039910A (zh) * 2019-12-31 2020-04-21 云南大学 一种光引发的合成3-芳基黄酮或香豆素类化合物的方法及应用
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL124481C (pt) 1964-11-04
US5395842A (en) 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
US5686465A (en) 1988-10-31 1997-11-11 Endorecherche Inc. Sex steroid activity inhibitors
IN173337B (pt) 1989-11-08 1994-04-02 Council Scient Ind Res
DE69023906T2 (de) 1990-08-09 1996-04-11 Council Scient Ind Res Benzopyrane und Verfahren zu deren Herstellung.
US6060503A (en) 1991-12-02 2000-05-09 Endorecherche, Inc. Benzopyran-containing compounds and method for their use
US5726186A (en) 1995-09-08 1998-03-10 Eli Lilly And Company Pentacyclic compounds, intermediates, processes, compositions, and methods
CA2214196A1 (en) 1996-09-26 1998-03-26 Eli Lilly And Company Benzo[b]indeno[2,1-d]thiophene compounds, intermediates, processes, compositions and methods
WO1998025916A1 (en) 1996-12-13 1998-06-18 C & C Research Laboratories Novel benzopyran derivatives
RU2305099C2 (ru) 2001-12-19 2007-08-27 Орто-Макнейл Фармасьютикал, Инк. Тетрациклические гетеросоединения в качестве модуляторов эстрогенных рецепторов

Also Published As

Publication number Publication date
AU2003295822A1 (en) 2004-06-23
US7329654B2 (en) 2008-02-12
CN1745085A (zh) 2006-03-08
RU2331645C2 (ru) 2008-08-20
NZ539914A (en) 2008-03-28
RU2005116845A (ru) 2006-01-20
JP2006514941A (ja) 2006-05-18
EP1569939A1 (en) 2005-09-07
WO2004050660A1 (en) 2004-06-17
ZA200505324B (en) 2006-09-27
PL376803A1 (pl) 2006-01-09
MXPA05005897A (es) 2006-02-08
CA2505857A1 (en) 2004-06-17
CN101450950A (zh) 2009-06-10
US20030216463A1 (en) 2003-11-20

Similar Documents

Publication Publication Date Title
BR0316843A (pt) Derivados tetracìclicos contendo heteroátomo como moduladores seletivos do receptor de estrogênio
DOP2015000276A (es) Derivados de 17–hidroxi–17–pentafluoroetil–estra–4,9(10)–dien–11–arilo con accion antagonista en el receptor de progesterona
BR0215152A (pt) Heterocompostos tetracìclicos como moduladores de receptores de estrogênio
ME00292B (me) Drospirenon za terapiju zamjene hormona
WO2007016385A3 (en) Use of substituted 5-amino-1h-pyrrole-2-carbonitrile derivatives as progesterone receptor modulators
BR0312024A (pt) Uso de derivados de ciclotiocarbamato no tratamento de condições relacionadas com hormÈnios
FI963049A (fi) Progesteroniantagonisteja lääkeaineiden valmistamiseksi, jotka on tarkoitettu kohdun toimintahäiriöistä johtuvien verenvuotojen hoitamiseksi
ATE334139T1 (de) 17 beta-nitro-11 beta-arylsteroide und deren derivate mit hormonalen agonist- oder antagonisteigenschaften
EA201491344A1 (ru) Производные спироиндолина в качестве антагонистов рецептора гонадотропин-рилизинг гормона
BRPI0511796A (pt) derivado de propano-1, 3-diona ou seu sal
NZ515353A (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
DE602005019905D1 (de) -modulatoren
ECSP055530A (es) Estratrienos 9-alfa-sustituidos como estrógenos de eficacia selectiva
MA32477B1 (fr) Derives estratrienes comprenant des bioisosteres heterocycliques pour le cycle a phenolique
NO20005145D0 (no) FremgangsmÕte for behandling av fertilitetsproblemer
ECSP078043A (es) Derivados de benzofurarona como moduladores no esteroides de receptores de progesterona
MXPA05011243A (es) Benzopiranos substituidos como agonistas selectivos del receptor beta de estrogeno.
ATE275973T1 (de) Empfängnisverhütende zusammensetzungen die progestagen und progesteronantagonisten enthalten
PT1809602E (pt) Derivados de indole úteis como moduladores do receptor da progesterona
EA201000097A1 (ru) 8-бета-замещенные эстратриены в качестве селективно активных эстрогенов
TN2011000022A1 (en) Estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a - ring
CU20110018A7 (es) Derivados de estratrieno que comprenden bioisósteros heterocíclicos para el anillo fenólico a
UY26967A1 (es) Derivados 8beta-sustituidos de 11beta-pentil y 11beta-hexil-estra-1,3,5(10)-trieno.-

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: JOHNSON AND JOHNSON (US)

Free format text: TRANSFERIDO DE: ORTHO-MCNEIL PHARMACEUTICAL, INC.

B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: C22D 3/06, C22B 3/10, C22B 11/00

Ipc: C07D 493/04 (2010.01)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.